Mechanisms of GM-CSF effect in CNS autoimmune demyelination
Mechanisms of GM-CSF effect in CNS autoimmune demyelination
批准号:
10062792
负责人:
A.M. Rostami
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-15 至 2023-11-30
关键词:
AcuteAnimal ModelAntigen-Presenting CellsAutoimmuneAutoimmune DiseasesB-LymphocytesCD4 Positive T LymphocytesCNS autoimmunityCellsChronicChronic PhaseColony-Stimulating Factor ReceptorsDataDemyelinationsDendritic CellsDevelopmentDiseaseExperimental Autoimmune EncephalomyelitisFOXP3 geneGranulocyte-Macrophage Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating Factor ReceptorsHematopoieticHumanIn VitroInflammatoryInterleukin-10KnowledgeLymphoid CellMediator of activation proteinMicrogliaMultiple SclerosisMusNerve RegenerationPathogenesisPathogenicityPeripheralPhenotypePlayProductionRegulatory T-LymphocyteRoleSignal TransductionSystemT-LymphocyteTestingTh1 CellsTherapeutic EffectTimeTissuesTransforming Growth Factor betabasecellular targetingcytokinehuman modelimmunoregulationin vivointerleukin-23macrophagemonocytemonocyte colony stimulating factormultiple sclerosis patientnovelnovel therapeutics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pro-inflammatory
cytokine essential for the development and progression of experimental autoimmune
encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Although GM-CSF is
mainly produced by pathogenic Th17 and Th1 cells, GM-CSF receptor (GM-CSFR) is not
expressed on T and B cells, but is expressed on antigen-presenting cells (APCs). Among them,
Ly6ChiCCR2+ monocytes are essential for the pathogenic role of GM-CSF in EAE. Further, GM-
CSF signaling in peripheral, but not CNS cells, plays a vital role in the development of acute
EAE. However, whether lack of GM-CSF signaling results in development of immunoregulatory
APCs has not been studied, and the role of GM-CSF signaling in CNS cells in EAE chronicity,
for which microglia activation plays a major role, remains unknown.
Our preliminary results for the first time show enhanced production of immunoregulatory
molecules in APCs, and increased IL-10 and Foxp3 expression in CD4+ T cells of mice lacking
GM-CSF. Similarly, neutralizing GM-CSF in human monocyte culture results in an increase of
IL-27 and TGF-β production. Based on these observations, we hypothesize that GM-CSF
induces proinflammatory monocytes, whereas its blockade results in the induction of
immunoregulatory APCs and suppression of EAE. We will test this hypothesis in the following
specific aims: 1) To determine the impact of GM-CSF on phenotype of APCs and T cells in
EAE. We will test the hypothesis that blockade of GM-CSF signaling in monocytes leads to the
development of immunoregulatory APCs that promote development of Tr1/Treg cells, resulting
in suppression of EAE. 2) To investigate the effect of GM-CSF on the phenotype of
microglia/macrophages in chronic phase of EAE. We will test our hypothesis that GM-CSF
promotes activation and pro-inflammatory M1 phenotype of macrophages/microglia in chronic
phase of EAE, which contributes to disease chronicity. 3) To determine the effects of blocking
GM-CSF on phenotype and function of human monocytes. We will test the hypothesis that
GM-CSF promotes development of a proinflammatory phenotype of human monocytes. These
studies should fill the gap in our knowledge on mechanisms of proinflammatory action of GM-
CSF and its relevant cellular targets in EAE/MS, with potential therapeutic effect in certain
autoimmune diseases.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
氯喹处理的树突状细胞需要STAT1信号传导其耐受性活性。
DOI:
10.1002/eji.201747362
发表时间:
2018-07
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Thome R, Bonfanti AP, Rasouli J, Mari ER, Zhang GX, Rostami A, Verinaud L]
通讯作者:
Verinaud L
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
IL-9 通过抑制 GM-CSF 产生来控制中枢神经系统自身免疫。
DOI:
10.4049/jimmunol.1801113
发表时间:
2020
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Yoshimura,Satoshi, Thome,Rodolfo, Konno,Shingo, Mari,ElisabethR, Rasouli,Javad, Hwang,Daniel, Boehm,Alexandra, Li,Yanhua, Zhang,Guang-Xian, Ciric,Bogoljub, Rostami,Abdolmohamad]
通讯作者:
Rostami,Abdolmohamad
DOI:
10.1126/scitranslmed.aba0599
发表时间:
2020-11-04
期刊:
Science translational medicine
影响因子:
17.1
作者:
[Casella G, Rasouli J, Boehm A, Zhang W, Xiao D, Ishikawa LLW, Thome R, Li X, Hwang D, Porazzi P, Molugu S, Tang HY, Zhang GX, Ciric B, Rostami A]
通讯作者:
Rostami A
DOI:
10.1016/j.jneuroim.2017.12.017
发表时间:
2018-04-15
期刊:
Journal of neuroimmunology
影响因子:
3.3
作者:
[Imitola J, Rasouli J, Watanabe F, Mahajan K, Sharan AD, Ciric B, Zhang GX, Rostami A]
通讯作者:
Rostami A
DOI:
10.3389/fimmu.2017.01392
发表时间:
2017
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Thomé R, Moore JN, Mari ER, Rasouli J, Hwang D, Yoshimura S, Ciric B, Zhang GX, Rostami AM]
通讯作者:
Rostami AM
ThGM Cells in CNS Autoimmunity
-
批准号:10449359
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:A.M. Rostami
-
依托单位:
IL-37: a novel regulator of inflammation in CNS autoimmunity
-
批准号:10199564
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:A.M. Rostami
-
依托单位:
ThGM Cells in CNS Autoimmunity
-
批准号:10299105
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:A.M. Rostami
-
依托单位:
IL-37: a novel regulator of inflammation in CNS autoimmunity
-
批准号:10369694
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:A.M. Rostami
-
依托单位:
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
-
批准号:10115612
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:A.M. Rostami
-
依托单位:
Role of IL-7R in CNS autoimmunity
-
批准号:10308115
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:A.M. Rostami
-
依托单位:
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
-
批准号:10361415
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:A.M. Rostami
-
依托单位:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
-
批准号:8911388
-
项目类别:
-
资助金额:$34.11万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The role of IL-27 in iv tolerance in EAE
-
批准号:8897994
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
-
批准号:8767198
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
-
批准号:9128718
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The role of IL-27 in iv tolerance in EAE
-
批准号:8761992
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
-
批准号:9298717
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
The role of IL-27 in iv tolerance in EAE
-
批准号:9304968
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:A.M. Rostami
-
依托单位:
Philadelphia Autoimmunity Center of Excellence
-
批准号:7828173
-
项目类别:
-
资助金额:$59.85万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
Anti-Inflammatory mechanisms of soybean-derived Bowman-Birk protease inhibitor
-
批准号:7893121
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
Philadelphia Autoimmunity Center of Excellence
-
批准号:8261980
-
项目类别:
-
资助金额:$57.57万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
Philadelphia Autoimmunity Center of Excellence
-
批准号:8070455
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
Investigation of Th 17 cells in Multiple Sclerosis
-
批准号:7688880
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
Anti-Inflammatory mechanisms of soybean-derived Bowman-Birk protease inhibitor
-
批准号:8103064
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2009
-
负责人:A.M. Rostami
-
依托单位:
海外基金